Page 5 - Qiagen Statdx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Qiagen statdx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Qiagen Statdx Today - Breaking & Trending Today

Qiagen (NYSE:QGEN) Issues Earnings Results, Beats Estimates By $0.01 EPS

Qiagen (NYSE:QGEN – Get Free Report) issued its earnings results on Monday. The company reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.01, Briefing.com reports. The company had revenue of $476.00 million for the quarter, compared to analysts’ expectations of $469.79 million. Qiagen had a net margin of 17.01% and […] ....

Robertw Baird , Vanguard Group Inc , Qiagen Company Profile , Dimensional Fund Advisors , Raymond James Associates , Jpmorgan Chase Co , Sei Investments Co , Get Free Report , Fund Advisors , Vanguard Group , Qiagen Daily , Nyse Qgen ,

Qiagen (NYSE:QGEN) Issues FY23 Earnings Guidance

Qiagen (NYSE:QGEN – Get Free Report) issued an update on its FY23 earnings guidance on Monday morning. The company provided EPS guidance of $2.07 for the period, compared to the consensus EPS estimate of $2.06. The company issued revenue guidance of $1.97 billion, compared to the consensus revenue estimate of $1.97 billion. Qiagen Price Performance […] ....

Robertw Baird , Macquarie Group Ltd , Victory Capital Management Inc , Qiagen Company Profile , Cetera Advisor Networks , Vident Investment Advisory , Get Free Report , Moderate Buy , Financial Advisors , Capital Management , Advisor Networks , Qiagen Daily , Nyse Qgen ,

QIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CER

Q3 2023: Net sales of $476 million (-5% at actual rates, -6% at constant exchange rates, CER); diluted EPS of $0.34 and adjusted diluted EPS of $0.50 // Net sales at CER of $470 million ahead of outlook for at least $465 million CER and adjusted diluted EPS of $0.50 CER ahead of outlook for at least $0.48 CER // 5% CER sales growth in non-COVID portfolio to $442 million, supported by higher sales from instruments as well as recurring consumables and related revenues // 9M 2023: 8% CER sales grow ....

City Of , United Kingdom , New York , United States , Thierry Bernard , John Gilardi , Thomas Theuringer , Daniela Berheide , Phoebe Loh , Exchange Commission , Us Securities Exchange , Life Sciences , Frankfurt Prime Standard , Molecular Diagnostics , Chief Executive Officer , Chief Financial Officer , Exchange Act , Annual Report , Sales Results ,

Handelsbanken Fonder AB Buys 8,400 Shares of Qiagen (NYSE:QGEN)

Handelsbanken Fonder AB grew its stake in shares of Qiagen (NYSE:QGEN – Free Report) by 24.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,200 shares of the company’s stock after buying an additional 8,400 shares during the period. Handelsbanken Fonder […] ....

Dekabank Deutsche Girozentrale , Robertw Baird , Barclays Plc , Exchange Commission , Norges Bank , Citigroup Inc , Handelsbanken Fonder , Free Report , Bank Deutsche Girozentrale , Stock Down , Get Free Report , Visit Holdingschannel , Qiagen Daily , Nyse Qgen , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,